Clinical trial

R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer

NCT00005989

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-11-01

PhasePHASE2

Study timeline

Study start (unknown)2002-11-01Date precision: month

Registry last updated2011-08-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

tipifarnibDRUG

Sponsors & collaborators

Mayo Cliniclead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

ChicagoIllinois, United States1 JacksonvilleFlorida, United States1 RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00005989 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.